{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-23-000682","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2023-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.281100+00:00","generated_at":"2026-06-13T13:55:20.723493+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BioSig subsidiary raises $1.71M in private placement; parent retains 87.5% ownership","bullets":["BioSig AI Sciences sold 1,710,000 shares to accredited investors at $1.00/share, raising $1.71M.","Before the placement BioSig owned 100% of BioSig AI; after closing it holds about 87.5%.","Laidlaw & Co (UK) Ltd received a warrant to buy 90,000 shares at $1.00, exercisable for 5 years.","Shares and Laidlaw warrant issued under Section 4(a)(2) and Regulation D exemption."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-23-000682","json":"https://secwatch.observer/filing/0001185185-23-000682.json","markdown":"https://secwatch.observer/filing/0001185185-23-000682.md","text":"https://secwatch.observer/filing/0001185185-23-000682.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000682/0001185185-23-000682-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000682/biosig20230630_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T13:55:20.723493+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1af65ad41a0f6c19412951f2256afd23575ebe28","claim":"Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1,710,000 (effective 2023-06-30).","evidence_excerpt":"On June 30, 2023, BioSig AI Sciences, Inc., f/k/a NeuroClear Technologies Inc. (“BioSig AI”), a subsidiary of BioSig Technologies, Inc. (“BioSig”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which BioSig AI agreed to sell an aggregate of 1,710,000 shares (the “Shares”) of BioSig AI’s common stock, par value $0.001 per share (the “Common Stock”) for an aggregate purchase price of $1,710,000 (the “BioSig AI Private Placement”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000682/0001185185-23-000682-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"$1,710,000"},{"label":"Effective","value":"2023-06-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}